BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29549162)

  • 1. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers.
    Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X
    Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162
    [No Abstract]   [Full Text] [Related]  

  • 2. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
    Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
    Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.
    Choi JH; Hwang YP; Kim HG; Khanal T; Do MT; Jin SW; Han HJ; Lee HS; Lee YC; Chung YC; Jeong TC; Jeong HG
    Nutr Cancer; 2014; 66(1):140-51. PubMed ID: 24341702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.
    Chihara Y; Shimoda M; Hori A; Ohara A; Naoi Y; Ikeda JI; Kagara N; Tanei T; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Breast Cancer Res Treat; 2017 Nov; 166(1):55-68. PubMed ID: 28702892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer.
    Di L; Liu LJ; Yan YM; Fu R; Li Y; Xu Y; Cheng YX; Wu ZQ
    J Exp Clin Cancer Res; 2019 Mar; 38(1):134. PubMed ID: 30898152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.
    Zubeldia IG; Bleau AM; Redrado M; Serrano D; Agliano A; Gil-Puig C; Vidal-Vanaclocha F; Lecanda J; Calvo A
    Exp Cell Res; 2013 Feb; 319(3):12-22. PubMed ID: 23153552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
    Jeon MJ; Kim WG; Lim S; Choi HJ; Sim S; Kim TY; Shong YK; Kim WB
    Mol Cell Endocrinol; 2016 Jan; 419():113-23. PubMed ID: 26463583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin suppresses the invasive ability of pancreatic cancer cells by blocking autocrine TGF‑β1 signaling.
    Duan W; Qian W; Zhou C; Cao J; Qin T; Xiao Y; Cheng L; Li J; Chen K; Li X; Ma J; Ma Q
    Oncol Rep; 2018 Sep; 40(3):1495-1502. PubMed ID: 29956804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad2/3-Regulated Expression of DLX2 Is Associated with Radiation-Induced Epithelial-Mesenchymal Transition and Radioresistance of A549 and MDA-MB-231 Human Cancer Cell Lines.
    Choi YJ; Baek GY; Park HR; Jo SK; Jung U
    PLoS One; 2016; 11(1):e0147343. PubMed ID: 26799321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch prevents transforming growth factor-beta-assisted epithelial-mesenchymal transition in cultured limbal progenitor cells through the induction of Smad7.
    Tsai TH; Sun MH; Ho TC; Ma HI; Liu MY; Tsao YP
    Mol Vis; 2014; 20():522-34. PubMed ID: 24791137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-mediated motility receptor confers resistance to chemotherapy
    Zhang H; Ren L; Ding Y; Li F; Chen X; Ouyang Y; Zhang Y; Zhang D
    FASEB J; 2019 May; 33(5):6365-6377. PubMed ID: 30802150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 β-induced SMAD2/3 linker modifications are TAK1 dependent and delay TGFβ signaling in primary human mesenchymal stem cells.
    van den Akker GG; van Beuningen HM; Vitters EL; Koenders MI; van de Loo FA; van Lent PL; Blaney Davidson EN; van der Kraan PM
    Cell Signal; 2017 Dec; 40():190-199. PubMed ID: 28943409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma.
    Morabito M; Larcher M; Cavalli FM; Foray C; Forget A; Mirabal-Ortega L; Andrianteranagna M; Druillennec S; Garancher A; Masliah-Planchon J; Leboucher S; Debalkew A; Raso A; Delattre O; Puget S; Doz F; Taylor MD; Ayrault O; Bourdeaut F; Eychène A; Pouponnot C
    EMBO Mol Med; 2019 Aug; 11(8):e9830. PubMed ID: 31328883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.
    Huang F; Shi Q; Li Y; Xu L; Xu C; Chen F; Wang H; Liao H; Chang Z; Liu F; Zhang XH; Feng XH; Han JJ; Luo S; Chen YG
    Cancer Res; 2018 Nov; 78(21):6073-6085. PubMed ID: 30171053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFβ1-Smad Signaling Pathway Participates in Interleukin-33 Induced Epithelial-to-Mesenchymal Transition of A549 Cells.
    Tan QY; Cheng ZS
    Cell Physiol Biochem; 2018; 50(2):757-767. PubMed ID: 30308508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity.
    Rypens C; Marsan M; Van Berckelaer C; Billiet C; Melis K; Lopez SP; van Dam P; Devi GR; Finetti P; Ueno NT; Bertucci F; Dirix P; Neven P; Vermeulen P; Dirix L; Van Laere SJ
    Breast Cancer Res Treat; 2020 Apr; 180(2):385-395. PubMed ID: 32043194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P311 induces the transdifferentiation of epidermal stem cells to myofibroblast-like cells by stimulating transforming growth factor β1 expression.
    Li H; Yao Z; He W; Gao H; Bai Y; Yang S; Zhang L; Zhan R; Tan J; Zhou J; Takata M; Wu J; Luo G
    Stem Cell Res Ther; 2016 Dec; 7(1):175. PubMed ID: 27906099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling.
    González-González A; Muñoz-Muela E; Marchal JA; Cara FE; Molina MP; Cruz-Lozano M; Jiménez G; Verma A; Ramírez A; Qian W; Chen W; Kozielski AJ; Elemento O; Martín-Salvago MD; Luque RJ; Rosa-Garrido C; Landeira D; Quintana-Romero M; Rosato RR; García MA; Ramirez-Tortosa CL; Kim H; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Lorente JA; Sánchez-Rovira P; Chang JC; Granados-Principal S
    Clin Cancer Res; 2018 Nov; 24(22):5697-5709. PubMed ID: 30012564
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.